CN Announces New Normal Course Issuer Bid for Share Repurchase and 3% Dividend Increase

CN Announces New Normal Course Issuer Bid for Share Repurchase and 3% Dividend Increase GlobeNewswire January 30, 2026 MONTREAL, Jan. 30, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a 3% increase in the 2026 dividend on the Company's outstanding common shares as well as […]

Dr. David Berman to Join Moderna as Chief Development Officer

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company’s Chief Development Officer, beginning March 2, 2026. He will serve on Moderna’s Executive Committee and report to Chief Executive Officer Stéphane Bancel. Dr. Jacqueline Miller will step down as

MasterCraft Boat Holdings, Inc. to Webcast Fiscal Second Quarter 2026 Earnings Conference Call Thursday, February 5, 2026

(NasdaqGM:MCFT), VONORE, Tenn., Jan. 30, 2026 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) will host a live webcast of its fiscal second quarter 2026 earnings conference call on Thursday, February 5, 2026, at 8:30 a.m. EST. Brad Nelson, Chief Executive Officer and Scott Kent, Chief Financial Officer, will discuss the Company's

Bonaccord Capital Partners Named 2025 Middle Market GP Stakes Firm of the Year by GP Stakes News

(NYSE:PX), DALLAS, Jan. 30, 2026 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, and Bonaccord Capital Partners (“Bonaccord”), a private equity firm focused on providing growth capital and strategic support to middle-market private markets sponsors, are pleased to announce that Bonaccord has been named 2025 Middle Market GP

Bladex’s Fourth Quarter 2025 Conference Call

Banco Latinoamericano de Comercio Exterior, S.A. (NYSE: BLX) cordially invites you to participate in its upcoming conference call to discuss its 4Q25 results Date and time:Friday, February 13, 202610:00 a.m. Eastern Time Presenting for Bladex:Mr. Jorge Salas, Chief Executive OfficerMrs. Annette van Hoorde de Solís, Chief Financial Officer Register for the Conference CallPlease click here

Solace Nutrition Announces Clinical and Scientific Updates for Encala®, the Original Structured-Lipid Medical Food for Fat Malabsorption

Solace Nutrition, a trusted leader in tailored clinical nutrition and medical foods, today announced significant clinical, scientific, and commercial updates for Encala®, its proprietary plant-based structured-lipid medical food designed to address fat malabsorption, fatty acid and choline deficiencies, poor growth in children, and unintentional weight loss in adults. Since the February 2025 relaunch of Encala,

UOB Kay Hian Expands Managed Account Capabilities Through Strategic Collaboration with inCadense

UOB Kay Hian is launching an enhanced managed account platform as part of its continued expansion of discretionary and advisory wealth solutions across its key markets in Asia, in collaboration with global managed-accounts provider inCadense®. UOB Kay Hian today announced the launch of an enhanced managed account platform as part of its continued expansion of

Society Pass Incorporated, NusaTrip Incorporated and Gother Establish Strategic Partnership to Enhance Flight Distribution in Projected US$84 Billion Thailand Travel Market

Society Pass Incorporated, NusaTrip Incorporated and Gother Establish Strategic Partnership to Enhance Flight Distribution in Projected US$84 Billion Thailand Travel Market GlobeNewswire January 30, 2026 JAKARTA, Indonesia, Jan. 30, 2026 (GLOBE NEWSWIRE) — Society Pass Incorporated (Nasdaq: SOPA) (the “Company“), Southeast Asia's next generation digital ecosystem, and its majority owned subsidiary, NusaTrip Inc (Nasdaq: NUTR)

CN Announces Solid Fourth Quarter and Year-End Results

CN Announces Solid Fourth Quarter and Year-End Results GlobeNewswire January 30, 2026 Fourth quarter diluted earnings per share (EPS) growth of 12%, or 14% on an adjusted basis (1) Fourth quarter operating ratio of 61.2%, or 60.1% on an adjusted basis (1) 2025 diluted EPS growth of 8%, or 7% on an adjusted basis (1)

Scroll to Top